Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bilopaque
2. Sodium Tyropanoate
3. Sodium, Tyropanoate
4. Tyropanoate
5. Tyropanoate, Sodium
6. Win 88512
7. Win-88512
8. Win88512
1. Sodium Tyropanoate
2. Bilopaque
3. Lumopaque
4. 7246-21-1
5. Bilopac
6. Tyropaque
7. Nsc-107434
8. Win 8851-2
9. Tyropanoate Sodium [usan]
10. Tyropanoic Acid Sodium Salt
11. Xrj0p5fayo
12. Sodium Tyropanoate [inn]
13. Win-8851-2
14. Sodium;2-[[3-(butanoylamino)-2,4,6-triiodophenyl]methyl]butanoate
15. Natrii Tyropanoas
16. Tyropanoate Sodium (usan)
17. Natrium Tyropanoat
18. Sodium Tyropanoate; Tyropanoat; Bilopac; Bilopaque; Lumopaque; Nsc 107434
19. Tiropanoato Sodico
20. Natrii Tyropanoas [inn-latin]
21. Tyropanoate De Sodium
22. Tiropanoato Sodico [inn-spanish]
23. Unii-xrj0p5fayo
24. Tyropanoate De Sodium [inn-french]
25. Einecs 230-653-9
26. Bilopaque?
27. Tyropanoate Sodium [usan:usp]
28. Bilopaque (tn)
29. Sodium 3-butyramido-.alpha.-ethyl-2,4,6-triiodohydrocinnamate
30. Natrium 2-(3-butyramido-2,4,6-triiodbenzyl)butyrat
31. Sodium 3-butyramido-alpha-ethyl-2,4,6-triiodohydrocinnamate
32. 2-(3-butyramido-2,4,6-triiodbenzyl)buttersaeure, Natrium-salz
33. Ncgc00181094-01
34. 3-butyramido-alpha-ethyl-2,4,6-triiodohydrocinnamic Acid Sodium Salt
35. Dsstox_cid_3729
36. Alpha-ethyl-beta-(2,4,6-triiodo-3-butyramidophenyl)propionic Acid Sodium Salt
37. Benzenepropanoic Acid, Alpha-ethyl-2,4,6-triiodo-3-((1-oxobutyl)amino)-, Monosodium Salt
38. Dsstox_rid_77169
39. Dsstox_gsid_23729
40. Schembl104929
41. Sodium Tyropanoate (jan/inn)
42. Tyropanoate Sodium [mi]
43. Chembl1200899
44. Dtxsid2023729
45. Sodium Tyropanoate [jan]
46. Chebi:32273
47. Tyropanoate Sodium [vandf]
48. Sodium Tyropanoate [mart.]
49. Sodium Tyropanoate [who-dd]
50. Tox21_112710
51. Hydrocinnamic Acid, 3-butyramido-alpha-ethyl-2,4,6-triiodo-, Monosodium Salt
52. Hydrocinnamic Acid, 3-butyramido-alpha-ethyl-2,4,6-triiodo-, Sodium Salt
53. Tyropanoate Sodium [orange Book]
54. Cas-7246-21-1
55. D01884
56. Q27293969
57. Sodium 2-{[3-(butanoylamino)-2,4,6-triiodophenyl]methyl}butanoate
58. Sodium-2-[(3-butanoylamino-2,4,6-triiodo-phenyl)methyl]butanoate
59. Benzenepropanoic Acid, .alpha.-ethyl-2,4,6-triiodo-3-((1-oxobutyl)amino)-, Monosodium Salt
| Molecular Weight | 663.00 g/mol |
|---|---|
| Molecular Formula | C15H17I3NNaO3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 7 |
| Exact Mass | 662.8240 g/mol |
| Monoisotopic Mass | 662.8240 g/mol |
| Topological Polar Surface Area | 69.2 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 400 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
ABOUT THIS PAGE
A Tyropanoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tyropanoate, including repackagers and relabelers. The FDA regulates Tyropanoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tyropanoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tyropanoate supplier is an individual or a company that provides Tyropanoate active pharmaceutical ingredient (API) or Tyropanoate finished formulations upon request. The Tyropanoate suppliers may include Tyropanoate API manufacturers, exporters, distributors and traders.
click here to find a list of Tyropanoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tyropanoate DMF (Drug Master File) is a document detailing the whole manufacturing process of Tyropanoate active pharmaceutical ingredient (API) in detail. Different forms of Tyropanoate DMFs exist exist since differing nations have different regulations, such as Tyropanoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tyropanoate DMF submitted to regulatory agencies in the US is known as a USDMF. Tyropanoate USDMF includes data on Tyropanoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tyropanoate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tyropanoate suppliers with USDMF on PharmaCompass.
Tyropanoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tyropanoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tyropanoate GMP manufacturer or Tyropanoate GMP API supplier for your needs.
A Tyropanoate CoA (Certificate of Analysis) is a formal document that attests to Tyropanoate's compliance with Tyropanoate specifications and serves as a tool for batch-level quality control.
Tyropanoate CoA mostly includes findings from lab analyses of a specific batch. For each Tyropanoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tyropanoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tyropanoate EP), Tyropanoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tyropanoate USP).
LOOKING FOR A SUPPLIER?
